Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Ovid Therapeutics (OVID) Shares Issued (2020 - 2025)

Ovid Therapeutics' Shares Issued history spans 6 years, with the latest figure at $75.1 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 12172.03% year-over-year to $75.1 million; the TTM value through Dec 2025 reached $75.1 million, changed N/A, while the annual FY2025 figure was $75.1 million, N/A changed from the prior year.
  • Shares Issued reached $75.1 million in Q4 2025 per OVID's latest filing, up from $15000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $75.1 million in Q4 2025 to a low of -$622000.0 in Q4 2024.
  • Average Shares Issued over 5 years is $4.0 million, with a median of $81629.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: plummeted 1984.85% in 2024, then soared 12172.03% in 2025.
  • A 5-year view of Shares Issued shows it stood at $313858.0 in 2021, then tumbled by 113.89% to -$43599.0 in 2022, then skyrocketed by 175.69% to $33000.0 in 2023, then tumbled by 1984.85% to -$622000.0 in 2024, then skyrocketed by 12172.03% to $75.1 million in 2025.
  • Per Business Quant, the three most recent readings for OVID's Shares Issued are $75.1 million (Q4 2025), $15000.0 (Q3 2025), and $13000.0 (Q1 2025).